Literature DB >> 28718827

Synthesis of 2H-Chromenones from Salicylaldehydes and Arylacetonitriles.

Chengcai Li1, Hailin Zhu2,3, Hang Zhang4, Yongfeng Yang5, Feng Wang6,7.   

Abstract

An efficient and convenient protocol for the synthesis of 2H-chromenones has been developed. In the presence of tBuOK in DMF, good to excellent yields of various chromenones were obtained from the corresponding salicylaldehydes and arylacetonitriles. No protection of inert gas atmosphere is required here.

Entities:  

Keywords:  chromenones synthesis; green chemistry; heterocycle synthesis; metal-free; salicylaldehydes

Mesh:

Substances:

Year:  2017        PMID: 28718827      PMCID: PMC6152355          DOI: 10.3390/molecules22071197

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


1. Introduction

Coumarin is an important class of benzo-fused six-membered heterocycles, which was first isolated as a natural product in 1820, and has been found to have various interesting bioactivities (Figure 1) [1,2,3,4,5,6,7,8]. Due to its importance, many efforts have been made to develop new synthetic procedures for coumarin’s preparation. Classical routes to coumarins based on Pechmann- [9], Knoevenagel- [10], Perkin- [11], Reformatsky- [12] and Wittig- [13] reactions have been extensively investigated. Recently, procedures based on transition metal catalysts, ionic liquids and microwaves have been developed as well [14,15,16,17].
Figure 1

Selected examples of bioactive chromenones.

In the 21st century, the demands of sustainable development drive organic chemists to pay more attention to the principles of green chemistry in designing their new procedures. Among the various possible directions, the development of new transition metal-free methodologies will be one attractive choice. On one hand, transition metal catalysts are usually considered to be toxic and non-environmentally benign. On the other hand, special attention has to be taken to avoid the problem of transition metal contamination of the final products, especially when in heterocycles synthesis chemistry. With these points in mind and also based on our continual interests in the development of new procedures for the synthesis of heterocycles under transition metal-free conditions [18], we wish to report here a convenient methodology for the construction of coumarins from salicylaldehydes and arylacetonitriles. In the presence of BuOK in DMF, good to excellent yields of the desired chromenones were obtained and no protection of inert gas atmosphere is required here.

2. Results and Discussion

Initially, we choose salicylaldehyde and 2-phenylacetonitrile as the model substrates to establish this reaction system (Table 1). As we expected, with two equivalents of BuOK as the base in 2 mL of dimethylformamide (DMF) at 110 °C, 77% of the desired product can be isolated (Table 1, entry 1). No better results can be obtained with an increased amount of promotor and similar yield can be observed with a higher concentration (Table 1, entries 2 and 3). Then, several other inorganic bases were screened and none of them could give better results than BuOK (Table 1, entries 5–10). The reaction temperature was also checked and yields were reduced when the reaction temperature was decreased or increased (Table 1, entries 11 and 12). Subsequently, various solvents were examined but without improved results (Table 1, entries 13–17).
Table 1

Optimization of the reaction conditions [a].

EntryBaseSolventT (°C)Yield (%) [b]
1tBuOKDMF [c]11077
2tBuOK [d]DMF [c]11075
3tBuOKDMF11081
4tBuOKDMF11048
80
5K2CO3DMF11034
6K3PO4DMF11055
7KOHDMF11027
8tBuOLiDMF11075
9NaOMeDMF11055
10tBuONaDMF11074
11tBuOKDMF9073
12tBuOKDMF13041
13tBuOKDMAc11054
14tBuOKDMSO11030
15tBuOKToluene1109
16tBuOKo-xylene11012
17tBuOK1,4-dioxane11015

[a] Reaction conditions: 1 (1 mmol), 2 (1.5 mmol), base (2.0 equiv.), solvent (1 mL), 110 °C, 16 h. [b] Isolated yields. [c] DMF (2 mL). [d] BuOK (3 equiv.).

With the optimal reaction conditions in hand, several substituted salicylaldehydes were tested and shown in Table 2. Moderate to good yields of 2H-chromenones can be obtained from the corresponding salicylaldehydes and 2-phenylacetonitrile.
Table 2

Synthesis of chromenones from salicylaldehydes [a].

EntrySubstrateProductYield (%) [b]
181
277
365
493
566
696
752
840
990

[a] Reaction conditions: 1a (1 mmol), 2 (1.5 mmol), BuOK (2.0 equiv.), DMF (1 mL), 110 °C, 16 h. [b] Isolated yields.

Then, various arylacetonitriles were examined with salicylaldehyde (Table 3). Both electron-donating and electron-withdrawing substituted phenylacetonitriles afforded the corresponding products in moderate to good yields. Notably, when 2-(2-fluorophenyl)acetonitrile and 2-(2-chlorophenyl)acetonitrile were applied as the reaction partner, good yields of dibenzo(b,f)oxepine-10-carbonitrile can be obtained via intermolecular condensation and intramolecular nucleophilic substitution (Table 3, entries 6 and 9) [19]. It is also important to mention that 3-oxo-3-phenylpropanenitrile, 3-phenylpropanenitrile and malononitrile were tested under standard conditions but no desired products can be detected (Table 3, entries 14–16).
Table 3

Synthesis of chromenones from 2-arylacetonitriles [a].

EntrySubstrateProductYield (%) [b]
181
277
365
470
570
686
778
893
968
1066
1170
1240
1351
140
150
160

[a] Reaction conditions: 1 (1 mmol), 2b (1.5 mmol), BuOK (2.0 equiv.), DMF (1 mL), 110 °C, 16 h. [b] Isolated yields.

To demonstrate the potential utility of this method, we conducted the reaction in gram scale as well (Scheme 1). Thus, salicylaldehyde (6 mmol) was reacted with phenylacetonitrile (8 mmol) in the presence of two equivalents; for BuOK at 110 °C for 20 h, 83% yield of 3-phenyl-2H-chromen-2-one was obtained (1.11 g).
Scheme 1

Gram scale synthesis of 3-phenyl-2H-chromen-2-one.

In addition, analogues of the substrates have been tested as well (Scheme 2). Under the standard conditions, 50% of 3-phenyl-2H-chromen-2-one and 21% of 2H-chromen-2-one could be obtained from methyl 2-phenylacetate and dimethyl malonate, respectively (Scheme 2, equation. a and equation. b). Moreover, 2-hydroxybenzonitrile, 2-acetylphenol and 2-hydroxybenzophenone were taken into consideration as well. Unfortunately, no desired product could be detected from 2-hydroxybenzonitrile (Scheme 2, equation. c). Interestingly, 2-acetylphenol could afford acceptable yield of the goal product (Scheme 2, equation. d) and moderate yield of 3,4-diphenyl-2H-chromen-2-one was generated from 2-hydroxybenzophenone and phenylacetonitrile without any further optimization (Scheme 2, equation. e) [20].
Scheme 2

Substrate analogues testing. (a) methyl 2-phenylacetate (b) dimethyl malonate (c) 2-hydroxybenzonitrile (d) 2-acetylphenol (e) 2-hydroxybenzophenone.

In order to obtain more insight into the reaction pathway, control experiments were performed (Scheme 3). Benzaldehyde, phenol and 4-hydroxybenzaldehyde were reacted with phenylacetonitrile under the standard reaction conditions, respectively. When benzaldehyde was reacted with phenylacetonitrile, 67% of 2,3-diphenylacrylonitrile was obtained while no product could be detected with phenol (Scheme 3, equation. a and equation. b). Compared with salicylaldehyde, 4-hydroxybenzaldehyde is considered as a compound with the same electron properties. Under the same reaction conditions, 93% of 3-(4-hydroxyphenyl)-2-phenylacrylonitrile was generated as the sole product by the reaction of 4-hydroxybenzaldehyde with phenylacetonitrile (Scheme 3, equation. c), which indicated that the first step of this transformation is the intermolecular condensation instead of the nucleophilic addition [21].
Scheme 3

Control experiments. (a) Benzaldehyde (b) phenol (c) 4-hydroxybenzaldehyde.

Based on these results, a possible reaction pathway has been proposed (Scheme 4). In the presence of base, phenylacetonitrile transformed into cyano(phenyl)methanide, which subsequently reacted with salicylaldehyde to give intermediate I. With the assistance of the other equivalent base, the hydroxyl group of intermediate I was activated and then reacted with the cyano via an intramolecular addition. The final products will be formed after in situ hydrolysis.
Scheme 4

Proposed mechanism of the synthesis of chromenone.

3. Materials and Methods

3.1. Materials and General Procedures

3.1.1. Materials

General comments: All reactions were carried out under air. Reactions were monitored by TLC analysis (pre-coated silica gel plates with fluorescent indicator UV254, 0.2 mm) and visualized with 254 nm UV light. Chemicals were purchased from Aldrich (Tianjin, China), Alfa-Aesar (Tianjin, China), TCI (Shanghai, China) and unless otherwise noted were used without further purification. All compounds were characterized by 1H-NMR and 13C-NMR spectroscopy and recorded on Bruker (Beijing, China) AV 300 and AV 400 spectrometers. Gas-chromatography-mass-analysis was performed using an Agilent HP-5890 with an Agilent HP-5973 Mass Selective Detector (EI) and an HP-5-capillary column using helium as a carrier gas.

3.1.2. General Procedures

Salicylaldehyde (1 mmol) and two equivalents of BuOK were added in a 25 mL tube equipped with a stirring bar. Then, 1 mL of DMF and 2-phenylacetonitrile (1.5 mmol) were injected by syringe. After that, the tube was closed and heated up to 110 °C for 16 h. When the reaction was completed, the reaction mixture was cooled to room temperature. The reaction was quenched with distilled water and the solution was extracted with ethyl acetate. The crude product was purified by column chromatography (ethyl acetate/pentane = 1:25–1:8).

3.2. Synthesis of Adducts (Specific Spectral Reference Supplementary Materials)

3-Phenyl-2H-chromen-2-one: 7t1H-NMR (300 MHz, Chloroform-d) δ 7.74 (d, J = 0.6 Hz, 1H), 7.66–7.60 (m, 2H), 7.50–7.41 (m, 2H), 7.41–7.32 (m, 3H), 7.29 (dq, J = 7.7, 0.9 Hz, 1H), 7.25–7.19 (m, 1H). 13C-NMR (75 MHz, Chloroform-d) δ 160.55, 153.48, 139.83, 134.67, 131.36, 128.83, 128.49, 128.44, 128.33, 127.87, 124.46, 119.64, 116.42. GC-MS (EI, 70 ev): m/z (%) = 222 (M+, 100), 195 (14), 194 (93), 166 (12), 165 (89), 164 (16), 163 (10), 82 (11). 6-Methyl-3-phenyl-2H-chromen-2-one: 7u1H-NMR (300 MHz, Chloroform-d) δ 7.70 (s, 1H), 7.67–7.58 (m, 2H), 7.48–7.33 (m, 3H), 7.31–7.24 (m, 2H), 7.23–7.14 (m, 1H), 2.36 (s, 3H). 13C-NMR (75 MHz, Chloroform-d) δ 160.74, 151.61, 139.84, 134.81, 134.11, 132.40, 128.71, 128.48, 128.40, 128.14, 127.65, 119.36, 116.11, 20.76. GC-MS (EI, 70 ev): m/z (%) = 236 (M+, 100), 209 (10), 208 (67), 207 (62), 179 (24), 178 (40), 152 (16), 139 (10), 89 (12), 77 (13), 76 (12), 51 (11). 6-Fluoro-3-phenyl-2H-chromen-2-one: 1H-NMR (300 MHz, Chloroform-d) δ 7.75 (s, 1H), 7.73–7.67 (m, 2H), 7.50–7.41 (m, 3H), 7.35 (dddd, J = 8.8, 4.5, 1.8, 1.1 Hz, 1H), 7.29–7.19 (m, 2H). 13C-NMR (75 MHz, Chloroform-d) δ 160.17, 149.63, 138.73, 134.28, 129.52, 129.16, 128.54, 128.53, 120.28, 118.76 (d, J = 24.6 Hz), 118.05, 117.94, 113.05 (d, J = 23.9 Hz). GC-MS (EI, 70 ev): m/z (%) = 240 (M+, 94), 213 (15), 212 (96), 184 (15), 183 (100), 182 (12), 181 (10), 163 (11), 157 (13), 91 (10). HRMS (EI): Calcd. for [[M + H]+: C15H9FO2]+: 241.06593, found: 241.06566. 6-Chloro-3-phenyl-2H-chromen-2-one: 7t1H-NMR (300 MHz, Chloroform-d) δ 7.73 (t, J = 0.5 Hz, 1H), 7.72–7.66 (m, 2H), 7.53 (d, J = 2.4 Hz, 1H), 7.50–7.41 (m, 4H), 7.31 (dt, J = 8.8, 0.6 Hz, 1H). 13C-NMR (75 MHz, Chloroform-d) δ 160.02, 151.88, 138.45, 134.25, 131.31, 129.75, 128.69–128.43 (m), 129.56, 129.25, 128.58, 127.10, 120.73, 117.93. GC-MS (EI, 70 ev): m/z (%) = 256 (M+, 100), 230 (30), 229 (15), 166 (10), 165 (77), 164 (20), 163 (28), 139 (18), 82 (18), 63 (15). Methyl-2-oxo-3-phenyl-2H-chromene-6-carboxylate: 7t1H-NMR (300 MHz, Chloroform-d) δ 8.28 (d, J = 2.0 Hz, 1H), 8.19 (dd, J = 8.7, 2.0 Hz, 1H), 7.89–7.84 (m, 1H), 7.76–7.65 (m, 2H), 7.55–7.34 (m, 5H), 3.96 (s, 3H). 13C-NMR (75 MHz, Chloroform-d) δ 165.70, 159.85, 156.21, 139.23, 134.17, 132.28, 129.94, 129.19, 128.56, 128.50, 128.35, 126.59, 119.39, 116.65, 52.47. GC-MS (EI, 70 ev): m/z (%) = 280 (M+, 100), 252 (11), 249 (30), 221 (45), 193 (29), 165 (27), 164 (12), 163 (14), 139 (22), 83 (15). 8-Methyl-3-phenyl-2H-chromen-2-one: 7t1H-NMR (300 MHz, Chloroform-d) δ 7.79 (s, 1H), 7.75–7.64 (m, 2H), 7.51–7.27 (m, 5H), 7.19 (dd, J = 8.1, 7.0 Hz, 1H), 2.49 (s, 3H). 13C-NMR (75 MHz, Chloroform-d) δ 160.59, 151.78, 140.19, 134.76, 132.61, 129.02, 128.64, 128.43, 128.35, 127.80, 125.78, 125.56, 123.97, 119.29, 15.38. GC-MS (EI, 70 ev): m/z (%) = 236 (M+, 100), 209 (12), 208 (76), 207 (45), 179 (19), 178 (36), 165 (30), 152 (12), 89 (14), 77 (10), 76 (12). 6,8-Dichloro-3-phenyl-2H-chromen-2-one: 7v1H-NMR (300 MHz, Chloroform-d) δ 7.75–7.63 (m, 3H), 7.57 (d, J = 2.3 Hz, 1H), 7.48–7.39 (m, 4H). 13C-NMR (75 MHz, Chloroform-d) δ 158.81, 147.77, 137.89, 133.72, 131.20, 130.23, 129.50, 129.48, 128.60, 128.51, 125.61, 122.27, 121.44. GC-MS (EI, 70 ev): m/z (%) = 291 (M+, 63), 290 (94), 266 (11), 265 (10), 264 (65), 263 (16), 262 (100), 201 (20), 200 (10), 199 (62), 164 (28), 163 (60), 162 (10), 139 (10), 99 (16), 87 (11), 81 (19), 63 (10). 7-Chloro-3-phenyl-2H-chromen-2-one: 1H-NMR (300 MHz, Chloroform-d) δ 7.66 (s, 1H), 7.61–7.52 (m, 2H), 7.44–7.30 (m, 4H), 7.28–7.24 (m, 1H), 7.21–7.09 (m, 1H). 13C-NMR (75 MHz, Chloroform-d) δ 159.84, 153.66, 138.90, 137.23, 134.30, 129.03, 128.64, 128.49, 128.44, 128.26, 125.08, 124.91, 118.21, 116.73. GC-MS (EI, 70 ev): m/z (%) = 256 (M+, 100), 230 (16), 228 (100), 166 (12), 165 (85), 164 (27), 163 (28), 139 (16), 115 (14), 114 (12), 82 (11), 63 (15). HRMS (EI): Calcd. for [[M + H]+: C15H9ClO2]+: 257.03638, found: 257.03614. 2-Phenyl-3H-benzo[f]chromen-3-one: 7u1H-NMR (300 MHz, Chloroform-d) δ 8.36 (d, J = 1.7 Hz, 1H), 8.09 (d, J = 8.4 Hz, 1H), 7.83–7.68 (m, 2H), 7.67–7.59 (m, 2H), 7.50 (ddd, J = 8.4, 7.0, 1.4 Hz, 1H), 7.42–7.26 (m, 5H). 13C-NMR (75 MHz, Chloroform-d) δ 160.55, 153.04, 135.60, 135.00, 132.62, 130.23, 129.01, 128.80, 128.50 (d, J = 2.1 Hz), 128.12, 127.10, 125.96, 121.34, 116.58, 113.65. GC-MS (EI, 70 ev): m/z (%) = 272 (M+, 92), 245 (23), 244 (100), 243 (23), 215 (60), 213 (27), 189 (10), 122 (10), 107 (25), 94 (18). 3-(o-Tolyl)-2H-chromen-2-one: 7x1H-NMR (300 MHz, Chloroform-d) δ 7.65 (s, 1H), 7.60–7.46 (m, 2H), 7.39 (ddt, J = 8.2, 1.2, 0.6 Hz, 1H), 7.36–7.28 (m, 3H), 7.28–7.22 (m, 2H). 13C-NMR (75 MHz, Chloroform-d) δ 160.21, 153.80, 141.59, 136.82, 134.66, 131.41, 130.30, 129.73, 128.81, 127.81, 125.85, 124.43, 119.28, 116.55, 19.92. GC-MS (EI, 70 ev): m/z (%) = 236 (M+, 100), 220 (12), 219 (64), 208 (37), 207 (86), 189 (27), 179 (26), 178 (53), 177 (10), 176 (11), 165 (24), 152 (21), 117 (12), 115 (23), 89 (18), 76 (14), 63 (18), 39 (11). 3-(m-Tolyl)-2H-chromen-2-one: 7t1H-NMR (300 MHz, Chloroform-d) δ 7.76 (s, 1H), 7.55–7.43 (m, 4H), 7.37–7.22 (m, 3H), 7.22–7.16 (m, 1H), 2.39 (s, 3H). 13C-NMR (75 MHz, Chloroform-d) δ 160.55, 153.42, 139.70, 138.03, 134.59, 131.24, 129.59, 129.09, 128.44, 128.32, 127.81, 125.60, 124.40, 119.65, 116.36, 21.45. GC-MS (EI, 70 ev): m/z (%) = 236 (M+, 100), 209 (14), 208 (81), 207 (18), 179 (14), 178 (30), 165 (38), 152 (13), 117 (11), 89 (13), 63 (10). 3-(p-Tolyl)-2H-chromen-2-one: 7t1H-NMR (300 MHz, Chloroform-d) δ 7.67 (s, 1H), 7.55–7.47 (m, 2H), 7.45–7.35 (m, 2H), 7.25 (dt, J = 7.8, 0.9 Hz, 1H), 7.21–7.09 (m, 3H), 2.29 (s, 3H). 13C-NMR (75 MHz, Chloroform-d) δ 160.60, 153.32, 139.12, 138.82, 131.71, 131.10, 129.09, 128.31, 128.17, 127.74, 124.36, 119.68, 116.30, 21.23. GC-MS (EI, 70 ev): m/z (%) = 236 (M+, 100), 209 (10), 208 (62), 207 (37), 179 (13), 178 (28), 165 (26), 152 (12), 89 (11), 63 (10), 114 (12), 82 (11), 63 (15). 3-(Naphthalen-1-yl)-2H-chromen-2-one: 7t1H-NMR (300 MHz, Chloroform-d) δ 7.97–7.87 (m, 2H), 7.84–7.76 (m, 2H), 7.64–7.41 (m, 7H), 7.38–7.30 (m, 1H). 13C-NMR (75 MHz, Chloroform-d) δ 160.77, 153.97, 142.77, 133.66, 132.64, 131.65, 131.53, 129.36, 128.53, 128.37, 127.93, 127.63, 126.48, 126.07, 125.23, 124.54, 119.32, 116.68. GC-MS (EI, 70 ev): m/z (%) = 272 (M+, 100), 273 (19), 271 (79), 255 (11), 244 (24), 243 (50), 216 (11), 215 (58), 214 (10), 213 (28), 189 (17), 107 (18), 95 (17), 63 (11). 3-(4-Methoxyphenyl)-2H-chromen-2-one: 7t1H-NMR (300 MHz, Chloroform-d) δ 7.75 (s, 1H), 7.71–7.63 (m, 2H), 7.56–7.44 (m, 2H), 7.34 (ddd, J = 8.0, 1.3, 0.7 Hz, 1H), 7.31–7.23 (m, 1H), 7.02–6.90 (m, 2H), 3.85 (s, 3H). 13C-NMR (75 MHz, Chloroform-d) δ 160.74, 160.10, 153.24, 138.43, 130.95, 129.78, 127.81, 127.65, 127.02, 124.38, 119.79, 116.32, 113.87, 55.32. GC-MS (EI, 70 ev): m/z (%) = 252 (M+, 100), 224 (10), 210 (10), 209 (65), 181 (41), 152 (35). 3-(3-Methoxyphenyl)-2H-chromen-2-one: 7t1H-NMR (300 MHz, Chloroform-d) δ 7.81 (s, 1H), 7.53 (td, J = 7.4, 1.6 Hz, 2H), 7.40–7.32 (m, 2H), 7.32–7.25 (m, 3H), 6.95 (ddd, J = 8.1, 2.6, 1.2 Hz, 1H), 3.85 (s, 3H). 13C-NMR (75 MHz, Chloroform-d) δ 160.41, 159.48, 153.45, 139.94, 135.96, 131.40, 129.43, 128.09, 127.89, 124.44, 120.86, 119.55, 116.38, 114.47, 114.16, 55.32. GC-MS (EI, 70 ev): m/z (%) = 252 (M+, 100), 224 (46), 194 (10), 182 (10), 181 (68), 167 (10), 165 (21), 153 (13), 152 (62), 151 (16), 127 (10), 126 (14), 63 (16), 39 (10). 3-(4-Fluorophenyl)-2H-chromen-2-one: 7u1H-NMR (300 MHz, Chloroform-d) δ 7.79 (s, 1H), 7.75–7.64 (m, 2H), 7.54 (ddt, J = 7.6, 6.0, 1.8 Hz, 2H), 7.37 (dt, J = 8.8, 0.8 Hz, 1H), 7.34–7.27 (m, 1H), 7.19–7.06 (m, 2H). 13C-NMR (75 MHz, Chloroform-d) δ 164.70, 160.51, 153.47, 139.65, 131.48, 130.70, 130.39 (d, J = 8.3 Hz), 127.87, 127.30, 124.56, 119.54, 116.47, 115.46 (d, J = 21.6 Hz). GC-MS (EI, 70 ev): m/z (%) = 240 (M+, 93), 212 (100), 184 (14), 183 (81), 181 (14), 157 (19), 107 (12), 106 (21), 92 (12), 91 (13). 3-(3-Fluorophenyl)-2H-chromen-2-one: 7y1H-NMR (300 MHz, Chloroform-d) δ 7.79 (s, 1H), 7.56–7.47 (m, 2H), 7.47–7.38 (m, 2H), 7.38–7.28 (m, 2H), 7.27–7.19 (m, 1H), 7.05 (tdd, J = 8.3, 2.6, 1.1 Hz, 1H). 13C-NMR (75 MHz, Chloroform-d) δ 164.24, 160.57 (d, J = 61.2 Hz), 153.54, 140.38, 136.63 (d, J = 8.1 Hz), 131.78, 129.95 (d, J = 8.4 Hz), 128.04, 126.99 (d, J = 2.4 Hz), 124.61, 124.13 (d, J = 3.1 Hz), 119.36, 116.49, 115.84 (d, J = 7.0 Hz), 115.55 (d, J = 8.9 Hz). GC-MS (EI, 70 ev): m/z (%) = 240 (M+, 80), 212 (90), 183 (100), 157 (10), 63 (10). Dibenzo[b,f]oxepine-10-carbonitrile: 91H-NMR (300 MHz, Chloroform-d) δ 7.62 (dd, J = 8.1, 1.7 Hz, 1H), 7.54–7.41 (m, 3H), 7.35–7.18 (m, 5H). 13C-NMR (75 MHz, Chloroform-d) δ 158.30, 157.43, 142.37, 132.86, 131.91, 130.42, 128.29, 128.03, 126.17, 125.60, 125.41, 121.91, 121.67, 118.46, 113.99.GC-MS (EI, 70 ev): m/z (%) = 219 (M+, 100), 191 (25), 190 (93), 165 (12), 164 (30), 163 (25), 82 (10), 63 (12). 3-(3-Chlorophenyl)-2H-chromen-2-one: 1H-NMR (300 MHz, Chloroform-d) δ 7.83 (s, 1H), 7.70 (td, J = 1.7, 1.0 Hz, 1H), 7.64–7.59 (m, 1H), 7.59–7.51 (m, 2H), 7.42–7.37 (m, 2H), 7.37–7.28 (m, 2H). 13C-NMR (75 MHz, Chloroform-d) δ 160.15, 153.59, 140.43, 136.35, 134.38, 131.82, 129.68, 128.89, 128.54, 128.05, 126.96, 126.74, 124.63, 119.37, 116.53. GC-MS (EI, 70 ev): m/z (%) = 256 (M+, 100), 230 (27), 229 (17), 228 (95), 166 (10), 165 (80), 164 (22), 163 (27), 139 (12), 110 (10), 82 (13), 75 (12), 63 (12). HRMS (EI): Calcd. for [[M + H]+: C15H9ClO2]+: 257.03638, found: 257.03614. 3-(4-Chlorophenyl)-2H-chromen-2-one: 7t1H-NMR (300 MHz, Chloroform-d) δ 7.82 (d, J = 0.6 Hz, 1H), 7.71–7.62 (m, 2H), 7.59–7.50 (m, 2H), 7.46–7.40 (m, 2H), 7.37 (dt, J = 8.9, 0.8 Hz, 1H), 7.34–7.28 (m, 1H). 13C-NMR (75 MHz, Chloroform-d) δ 160.32, 153.52, 139.91, 134.92, 133.05, 131.66, 129.82, 128.67, 127.95, 127.15, 124.60, 119.46, 116.50. GC-MS (EI, 70 ev): m/z (%) = 256 (M+, 100), 230 (24), 229 (10), 228 (73), 165 (60), 164 (18), 163 (20). 3-(Pyridin-3-yl)-2H-chromen-2-one: 7z1H-NMR (300 MHz, Chloroform-d) δ 8.80 (d, J = 2.4 Hz, 1H), 8.61 (dd, J = 4.9, 1.7 Hz, 1H), 8.05 (d, J = 8.5 Hz, 1H), 7.28–7.22 (m, 1H), 7.44–7.31 (m, 3H), 7.25 (s, 1H), 7.14 (td, J = 7.6, 1.0 Hz, 2H). 13C-NMR (75 MHz, Chloroform-d) δ 153.33, 149.55, 149.14, 136.43, 134.27, 132.25, 130.90, 127.68, 123.61, 122.92, 119.62, 115.38. GC-MS (EI, 70 ev): m/z (%) = 221 (M+, 100), 222 (26), 139 (12). 4-Methyl-3-phenyl-2H-chromen-2-one: 7t1H-NMR (300 MHz, Chloroform-d) δ 7.69 (dd, J = 8.0, 1.5 Hz, 1H), 7.55 (ddd, J = 8.6, 7.2, 1.5 Hz, 1H), 7.50–7.36 (m, 4H), 7.36–7.28 (m, 3H), 2.32 (s, 3H). 13C-NMR (75 MHz, Chloroform-d) δ 160.93, 152.66, 147.59, 134.42, 131.29, 129.99, 128.40, 128.18, 127.33, 125.08, 124.22, 120.54, 116.85, 16.56. GC-MS (EI, 70 ev): m/z (%) = 236 (M+, 96), 235 (82), 208 (60), 207 (100), 179 (24), 178 (62), 177 (11), 176 (13), 165 (22), 152 (22), 151 (10), 139 (15), 131 (28), 115 (20), 102 (12), 89 (23), 77 (21), 75 (10), 63 (21), 51 (17), 50 (10), 39 (15). 3,4-Diphenyl-2H-chromen-2-one: 101H-NMR (300 MHz, Chloroform-d) δ 7.54 (ddd, J = 8.6, 6.6, 2.2 Hz, 1H), 7.44 (ddd, J = 8.3, 1.2, 0.6 Hz, 1H), 7.34–7.28 (m, 3H), 7.23–7.10 (m, 9H). 13C-NMR (75 MHz, Chloroform-d) δ 161.26, 153.22, 151.57, 134.46, 133.84, 131.43, 130.51, 129.35, 128.33, 128.25, 127.78, 127.73, 127.63, 126.99, 124.11, 120.51, 116.76. GC-MS (EI, 70 ev): m/z (%) = 298 (M+, 100), 297 (90), 281 (11), 270 (28), 269 (28), 268 (16), 255 (13), 253 (17), 252 (11), 241 (32), 240 (10), 239 (47), 165 (12), 119 (19). 2H-Chromen-2-one: 7m1H-NMR (300 MHz, Chloroform-d) δ 7.62 (d, J = 9.6 Hz, 1H), 7.50–7.35 (m, 2H), 7.30–7.13 (m, 2H), 6.34 (d, J = 9.5 Hz, 1H). 13C-NMR (75 MHz, Chloroform-d) δ 160.74, 154.03, 143.39, 131.80, 127.83, 124.39, 118.81, 116.88, 116.69. GC-MS (EI, 70 ev): m/z (%) = 146 (M+, 56), 118 (100), 90 (44), 89 (41), 64 (10), 63 (28), 62 (12). (Z)-2,3-Diphenylacrylonitrile: 111H-NMR (300 MHz, Chloroform-d) δ 7.98–7.85 (m, 2H), 7.73–7.64 (m, 2H), 7.55 (s, 1H), 7.52–7.39 (m, 6H). 13C-NMR (75 MHz, Chloroform-d) δ 142.20, 134.41, 133.66, 130.49, 129.22, 129.16, 129.02, 128.91, 125.95, 117.95, 111.64. GC-MS (EI, 70 ev): m/z (%) = 205 (M+, 100), 204 (92), 203 (26), 190 (52), 178 (23), 177 (27), 176 (24), 165 (13), 151 (13), 102 (12), 89 (14), 88 (11), 77 (11), 76 (16), 75 (11), 63 (13), 51 (22), 50 (14), 39 (11). (Z)-3-(4-Hydroxyphenyl)-2-phenylacrylonitrile: 111H-NMR (300 MHz, DMSO-d6) δ 10.29 (s, 1H), 7.93–7.76 (m, 3H), 7.75–7.64 (m, 2H), 7.54–7.43 (m, 2H), 7.42–7.31 (m, 1H), 6.92 (d, J = 8.7 Hz, 2H). 13C-NMR (75 MHz, DMSO-d6) δ 160.02, 142.91, 134.37, 131.44, 129.14, 128.61, 125.41, 124.79, 118.64, 115.89, 105.85. GC-MS (EI, 70 ev): m/z (%) = 221 (M+, 100), 206 (18), 204 (10), 203 (11), 202 (24), 192 (11), 191 (14) 190 (19), 177 (11), 165 (40), 164 (13), 63 (12), 51 (16), 39 (10).

4. Conclusions

In summary, a practical procedure for the synthesis of 3-aryl-2H-chromen-2-ones from salicylaldehydes and arylacetonitriles has been established. With BuOK as the promotor and DMF as the solvent, good to excellent yields of chromenones were obtained. Additionally, no protection of inert gas atmosphere is required here.
  14 in total

Review 1.  Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies.

Authors:  Anuradha Thakur; Ramit Singla; Vikas Jaitak
Journal:  Eur J Med Chem       Date:  2015-07-10       Impact factor: 6.514

2.  Imperatorin sensitizes anoikis and inhibits anchorage-independent growth of lung cancer cells.

Authors:  Kanuengnit Choochuay; Preedakorn Chunhacha; Varisa Pongrakhananon; Rataya Luechapudiporn; Pithi Chanvorachote
Journal:  J Nat Med       Date:  2012-10-30       Impact factor: 2.343

3.  Oral bioavailability, therapeutic efficacy and reactive oxygen species scavenging properties of coenzyme Q10-loaded polymeric nanoparticles.

Authors:  Nitin K Swarnakar; Amit K Jain; Raman P Singh; Chandraiah Godugu; Manasmita Das; Sanyog Jain
Journal:  Biomaterials       Date:  2011-06-24       Impact factor: 12.479

4.  Preparation of 3-Acyl-4-arylcoumarins via Metal-Free Tandem Oxidative Acylation/Cyclization between Alkynoates with Aldehydes.

Authors:  Xia Mi; Chenyang Wang; Mengmeng Huang; Yusheng Wu; Yangjie Wu
Journal:  J Org Chem       Date:  2014-12-15       Impact factor: 4.354

5.  Synthesis, structure-activity relationship of iodinated-4-aryloxymethyl-coumarins as potential anti-cancer and anti-mycobacterial agents.

Authors:  Mahantesha Basanagouda; Vishwanath B Jambagi; Nivedita N Barigidad; Sandeep S Laxmeshwar; Venkatesh Devaru
Journal:  Eur J Med Chem       Date:  2014-01-11       Impact factor: 6.514

6.  Synthesis of substituted 3-iodocoumarins and 3-iodobutenolides via electrophilic iodocyclization of ethoxyalkyne diols.

Authors:  Maddi Sridhar Reddy; Nuligonda Thirupathi; Madala Hari Babu; Surendra Puri
Journal:  J Org Chem       Date:  2013-06-03       Impact factor: 4.354

7.  One-pot transition-metal-free synthesis of dibenzo[b,f]oxepins from 2-halobenzaldehydes.

Authors:  Young Lok Choi; Hye Sun Lim; Hwan Jung Lim; Jung-Nyoung Heo
Journal:  Org Lett       Date:  2012-09-17       Impact factor: 6.005

8.  Dramatic enhancement of catalytic activity in an ionic liquid: highly practical Friedel-Crafts alkenylation of arenes with alkynes catalyzed by metal triflates.

Authors:  Choong Eui Song; Da-un Jung; Su Yhen Choung; Eun Joo Roh; Sang-gi Lee
Journal:  Angew Chem Int Ed Engl       Date:  2004-11-19       Impact factor: 15.336

9.  Structure-Activity Relationships of Synthetic Coumarins as HIV-1 Inhibitors.

Authors:  I Kostova; S Raleva; P Genova; R Argirova
Journal:  Bioinorg Chem Appl       Date:  2006-02-23       Impact factor: 7.778

10.  Tandem aldehyde-alkyne-amine coupling/cycloisomerization: A new synthesis of coumarins.

Authors:  Maddi Sridhar Reddy; Nuligonda Thirupathi; Madala Haribabu
Journal:  Beilstein J Org Chem       Date:  2013-01-28       Impact factor: 2.883

View more
  2 in total

Review 1.  3-Phenylcoumarins as a Privileged Scaffold in Medicinal Chemistry: The Landmarks of the Past Decade.

Authors:  Maria J Matos; Eugenio Uriarte; Lourdes Santana
Journal:  Molecules       Date:  2021-11-08       Impact factor: 4.411

Review 2.  Natural source, bioactivity and synthesis of 3-Arylcoumarin derivatives.

Authors:  Qiang Zhang; Yu-Hang Miao; Teng Liu; Yin-Ling Yun; Xiao-Ya Sun; Tao Yang; Jie Sun
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.